Susana Ruiz Mendoza
Overview
Explore the profile of Susana Ruiz Mendoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valente M, Martins Alcantara L, Cintra D, Mendoza S, Medeiros E, Gomes K, et al.
Microbiol Spectr
. 2024 Dec;
13(2):e0174624.
PMID: 39688412
Importance: has emerged as a critical public health concern due to its resistance to multiple antifungal drugs and ability to survive on surfaces under harsh conditions, mainly due to biofilm...
2.
Mendoza S, Ferreira M, Valente M, Guimaraes A
Methods Mol Biol
. 2024 May;
2775:307-328.
PMID: 38758326
The importance of humoral immunity to fungal infections remains to be elucidated. In cryptococcosis, patients that fail to generate antibodies against antigens of the fungus Cryptococcus neoformans are more susceptible...
3.
Medeiros E, Valente M, Honorato L, Ferreira M, Mendoza S, Goncalves D, et al.
mSystems
. 2024 May;
9(6):e0122623.
PMID: 38717186
We conducted a comprehensive comparative analysis of extracellular vesicles (EVs) from two strains, Neff (environmental) and T4 (clinical). Morphological analysis via transmission electron microscopy revealed slightly larger Neff EVs (average...
4.
Ferreira M, Goncalves D, Mendoza S, de Oliveira G, Pontes B, la Noval C, et al.
Appl Environ Microbiol
. 2024 Jan;
90(2):e0173623.
PMID: 38259076
In this study, we conducted an in-depth analysis to characterize potential () proteins capable of recognizing fungal β-1,3-glucans. specifically anchors curdlan or laminarin, indicating the presence of surface β-1,3-glucan-binding molecules....
5.
Mendoza S, Liedke S, Rodriguez de La Noval C, Ferreira M, Gomes K, Honorato L, et al.
Med Mycol
. 2022 Jul;
60(8).
PMID: 35867978
Lay Summary: Mycoses have increased worldwide, and new efficient therapeutics are needed. Passive immunizations targeting universally the fungal cell would allow early interventions without the species-level diagnosis. Lectins with affinity...
6.
Ferreira M, Mendoza S, Goncalves D, la Noval C, Honorato L, Nimrichter L, et al.
Front Cell Infect Microbiol
. 2022 Jun;
12:858979.
PMID: 35711659
() is a species of free-living amoebae (FLAs) that has been widely applied as a model for the study of host-parasite interactions and characterization of environmental symbionts. The sharing of...
7.
Mendoza S, Zamith-Miranda D, Takacs T, Gacser A, Nosanchuk J, Guimaraes A
J Fungi (Basel)
. 2021 Apr;
7(4).
PMID: 33800694
The prevalence of fungal infections has increased in immunocompromised patients, leading to millions of deaths annually. Arachidonic acid (AA) metabolites, such as eicosanoids, play important roles in regulating innate and...
8.
la Noval C, Mendoza S, Goncalves D, Ferreira M, Honorato L, Peralta J, et al.
J Fungi (Basel)
. 2020 Oct;
6(4).
PMID: 33120893
Aspergillosis cases by have increased, along with fungal resistance to antifungals, urging the development of new therapies. Passive immunization targeting common fungal antigens, such as chitin and β-glucans, are promising...